Friday, October 9, 2020

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study

Virologists have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters.

from Top Health News -- ScienceDaily https://ift.tt/3iLSmWr

No comments:

Post a Comment

Brain cancer may begin years before doctors can see it

Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years before a tumor ...